RECURRENT HIGH GRADE GLIOMA
Clinical trials for RECURRENT HIGH GRADE GLIOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT HIGH GRADE GLIOMA trials appear
Sign up with your email to follow new studies for RECURRENT HIGH GRADE GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Brain cancer patients get virus injection in new trial
Disease control Recruiting nowThis early-stage trial tests a virus-based drug (MVR-C5252) given directly into the brain tumor of people with recurrent high-grade glioma. The main goals are to check safety and find the best dose. About 51 adults with returning brain tumors will take part. If successful, it may…
Matched conditions: RECURRENT HIGH GRADE GLIOMA
Phase: PHASE1 • Sponsor: Duke University • Aim: Disease control
Last updated May 26, 2026 08:19 UTC
-
New hope for recurrent brain cancer? drug combo enters human testing
Disease control Recruiting nowThis early-phase study tests a new two-drug combination for adults whose high-grade glioma (a type of brain cancer) has come back after standard treatment. The drugs are a low, continuous dose of temozolomide (a chemotherapy pill) plus abexinostat (an experimental drug). The main…
Matched conditions: RECURRENT HIGH GRADE GLIOMA
Phase: PHASE1 • Sponsor: University of Nebraska • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
Immune cells engineered to hunt brain tumors in first human test
Disease control Recruiting nowThis early-phase study tests a new treatment for adults with glioblastoma or high-grade glioma that has come back after standard therapy. The treatment uses specially engineered natural killer (NK) cells designed to target two different markers on tumor cells at once, which may h…
Matched conditions: RECURRENT HIGH GRADE GLIOMA
Phase: PHASE1 • Sponsor: Beijing Biotech • Aim: Disease control
Last updated May 19, 2026 12:01 UTC